newyork,
The previous UU placement stipulated no placements below that price (roughly $1.25 "IIRC") for 90 days.
Yesterday's UU placement stipulated no placements below $2.50 for 180 days.
I am more comfortable with this placement. The financings have continued to improve over the past few years- no warrants included in the last several placements, and now- the promise of no placements for six months, or no placements under 2.50 for six months.
Again, I think this is the least of the evils. I would not want to see them give away anything too early. Would rather scrape along like this while more data comes in. They've got enough money now to fund trials til we see data from the cancer trial, HCV single-dose 6mg cohort, HCV multi-dose trial, and hopefully we'll also hear of preclinical SIV or SHIV data, and start of HIV trial, and obviously govt multi-viral data. All that- with this placement, over the next six months. - and PPHM remains sole owner of all bavi tech, for a less than 10 percent dilution.
Fine by me.
Whadya want- revenues?... :)
As for trading, good luck, sincerely.
j
Market Data 
Markets 
AI
